Results 31 to 40 of about 603,488 (260)

Book review Development of paradigmatic ideas in the domestic regional economics by Evgeny Animitsa et al.

open access: yesJournal of New Economy, 2023
The paper presents an overview of a monograph prepared by a team of scholars representing the Ural school of regional economics, which was created under the leadership of Evgeny Animitsa and is based in the Ural State University of Economics ...
Olga N. Buchinskaia
doaj   +1 more source

Reduced vascular leakage correlates with breast carcinoma T regulatory cell infiltration but not with metastatic propensity

open access: yesMolecular Oncology, EarlyView.
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He   +8 more
wiley   +1 more source

Local Authorities and Communicators Engaged in Science: PLACES Impact Assessment Case Study of Prague

open access: yesTeorie vědy, 2013
Local Authorities and Communicators Engaged in Science: PLACES* Impact Assessment Case Study of Prague Abstract: Regional aspects of science communication represent a potential asset and as such are quite suitable topic for further examination with ...
Adolf Filáček, Jakub Pechlát
doaj   +1 more source

SCIENCE-POLICY INTERFACE IN REGIONAL ENVIRONMENTAL MANAGEMENT: CASE OF HELCOM IN THE BALTIC CONTEXT

open access: yesСоціальна економіка, 2023
The regional environmental cooperation in the Baltic Sea is the leading and “forerunner” model for managing environmental challenges at the regional level.
Uyanga Tsenddorj, Buyandelger Doljin
doaj   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

open access: yesMolecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj   +4 more
wiley   +1 more source

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer

open access: yesMolecular Oncology, EarlyView.
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad   +35 more
wiley   +1 more source

Contemporary Regional Studies – Theory, Methodology and Practice

open access: yesStudia Regionalne i Lokalne, 2006
The paper offers a review of the evolution in defining and describing regions, showing mutual relationships between particular approaches and logical succession between various analytical concepts of the region.
Iwona Sagan
doaj  

Regional Science in a time of uncertainty

open access: yesREGION, 2016
I have given this paper the title  ‘Regional Science in a time of uncertainty’ because that is what it appears to be,  very much a time of uncertainty. Uncertainty is always with us, but what I mean is the future is more uncertain than usual.
Bernard Fingleton
doaj   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy